Mather Group LLC. Sells 5,128 Shares of CME Group Inc. (NASDAQ:CME)

Mather Group LLC. trimmed its position in shares of CME Group Inc. (NASDAQ:CME) by 71.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,041 shares of the financial services provider’s stock after selling 5,128 shares during the period. Mather Group LLC.’s holdings in CME Group were worth $430,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Kestra Advisory Services LLC raised its holdings in CME Group by 86.6% during the 3rd quarter. Kestra Advisory Services LLC now owns 5,763 shares of the financial services provider’s stock valued at $1,154,000 after buying an additional 2,675 shares during the period. V Square Quantitative Management LLC boosted its stake in shares of CME Group by 102.8% during the 3rd quarter. V Square Quantitative Management LLC now owns 2,028 shares of the financial services provider’s stock worth $406,000 after purchasing an additional 1,028 shares during the period. Azimuth Capital Investment Management LLC grew its holdings in CME Group by 2.3% during the 3rd quarter. Azimuth Capital Investment Management LLC now owns 9,533 shares of the financial services provider’s stock valued at $1,909,000 after purchasing an additional 215 shares during the last quarter. Regal Investment Advisors LLC raised its position in CME Group by 23.2% in the 3rd quarter. Regal Investment Advisors LLC now owns 14,930 shares of the financial services provider’s stock worth $2,989,000 after purchasing an additional 2,807 shares during the period. Finally, Dark Forest Capital Management LP lifted its stake in CME Group by 7.8% in the third quarter. Dark Forest Capital Management LP now owns 11,926 shares of the financial services provider’s stock worth $2,388,000 after purchasing an additional 865 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

Insider Activity at CME Group

In other news, Director Daniel R. Glickman sold 650 shares of CME Group stock in a transaction that occurred on Thursday, June 6th. The shares were sold at an average price of $201.44, for a total value of $130,936.00. Following the transaction, the director now owns 14,008 shares of the company’s stock, valued at approximately $2,821,771.52. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, Director Daniel R. Glickman sold 650 shares of the stock in a transaction on Thursday, June 6th. The stock was sold at an average price of $201.44, for a total transaction of $130,936.00. Following the completion of the sale, the director now owns 14,008 shares in the company, valued at approximately $2,821,771.52. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Hilda Harris Piell sold 7,140 shares of the firm’s stock in a transaction on Wednesday, May 8th. The stock was sold at an average price of $210.35, for a total value of $1,501,899.00. Following the completion of the sale, the insider now directly owns 29,256 shares of the company’s stock, valued at approximately $6,153,999.60. The disclosure for this sale can be found here. Insiders have sold a total of 54,290 shares of company stock valued at $11,393,700 over the last quarter. 0.30% of the stock is owned by corporate insiders.

CME Group Trading Up 1.0 %

NASDAQ CME opened at $198.49 on Friday. CME Group Inc. has a one year low of $177.97 and a one year high of $223.80. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.01 and a current ratio of 1.01. The company has a market capitalization of $71.47 billion, a price-to-earnings ratio of 22.58, a price-to-earnings-growth ratio of 5.20 and a beta of 0.52. The company’s 50-day simple moving average is $206.94 and its two-hundred day simple moving average is $209.48.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.44 by $0.06. The company had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.48 billion. CME Group had a net margin of 56.84% and a return on equity of 12.45%. CME Group’s revenue was up 3.2% compared to the same quarter last year. During the same period last year, the company posted $2.42 earnings per share. Equities analysts forecast that CME Group Inc. will post 9.72 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Friday, June 7th will be paid a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.32%. The ex-dividend date is Friday, June 7th. CME Group’s dividend payout ratio (DPR) is currently 52.33%.

Analysts Set New Price Targets

A number of research analysts have recently commented on the company. Morgan Stanley upped their target price on CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a research note on Tuesday, April 9th. Argus increased their target price on CME Group from $225.00 to $245.00 and gave the stock a “buy” rating in a research note on Wednesday, March 6th. Keefe, Bruyette & Woods boosted their target price on shares of CME Group from $222.00 to $226.00 and gave the company a “market perform” rating in a research note on Thursday, April 25th. JPMorgan Chase & Co. upped their price target on shares of CME Group from $198.00 to $206.00 and gave the stock a “neutral” rating in a report on Thursday, April 25th. Finally, Barclays lifted their price objective on shares of CME Group from $226.00 to $228.00 and gave the company an “equal weight” rating in a report on Thursday, April 25th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $217.80.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.